Copyright Reports & Markets. All rights reserved.

Global Heparin Sodium Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Heparin Sodium
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Heparin Sodium Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Type A
    • 1.3.3 Type B
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Heparin Sodium Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Standard Heparin Preparation
    • 1.4.3 Low Molecular Weight Heparin Preparations
  • 1.5 Global Heparin Sodium Market Size & Forecast
    • 1.5.1 Global Heparin Sodium Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Heparin Sodium Sales Quantity (2018-2029)
    • 1.5.3 Global Heparin Sodium Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Shenzhen Hepalink
    • 2.1.1 Shenzhen Hepalink Details
    • 2.1.2 Shenzhen Hepalink Major Business
    • 2.1.3 Shenzhen Hepalink Heparin Sodium Product and Services
    • 2.1.4 Shenzhen Hepalink Heparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Shenzhen Hepalink Recent Developments/Updates
  • 2.2 Nanjing King-friend
    • 2.2.1 Nanjing King-friend Details
    • 2.2.2 Nanjing King-friend Major Business
    • 2.2.3 Nanjing King-friend Heparin Sodium Product and Services
    • 2.2.4 Nanjing King-friend Heparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Nanjing King-friend Recent Developments/Updates
  • 2.3 Bioiberica
    • 2.3.1 Bioiberica Details
    • 2.3.2 Bioiberica Major Business
    • 2.3.3 Bioiberica Heparin Sodium Product and Services
    • 2.3.4 Bioiberica Heparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Bioiberica Recent Developments/Updates
  • 2.4 Dongcheng Biochemicals
    • 2.4.1 Dongcheng Biochemicals Details
    • 2.4.2 Dongcheng Biochemicals Major Business
    • 2.4.3 Dongcheng Biochemicals Heparin Sodium Product and Services
    • 2.4.4 Dongcheng Biochemicals Heparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Dongcheng Biochemicals Recent Developments/Updates
  • 2.5 Changzhou Qianhong Bio-pharma
    • 2.5.1 Changzhou Qianhong Bio-pharma Details
    • 2.5.2 Changzhou Qianhong Bio-pharma Major Business
    • 2.5.3 Changzhou Qianhong Bio-pharma Heparin Sodium Product and Services
    • 2.5.4 Changzhou Qianhong Bio-pharma Heparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Changzhou Qianhong Bio-pharma Recent Developments/Updates
  • 2.6 Pfizer
    • 2.6.1 Pfizer Details
    • 2.6.2 Pfizer Major Business
    • 2.6.3 Pfizer Heparin Sodium Product and Services
    • 2.6.4 Pfizer Heparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Pfizer Recent Developments/Updates
  • 2.7 Changshan Biochemical
    • 2.7.1 Changshan Biochemical Details
    • 2.7.2 Changshan Biochemical Major Business
    • 2.7.3 Changshan Biochemical Heparin Sodium Product and Services
    • 2.7.4 Changshan Biochemical Heparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Changshan Biochemical Recent Developments/Updates
  • 2.8 Aspen Oss
    • 2.8.1 Aspen Oss Details
    • 2.8.2 Aspen Oss Major Business
    • 2.8.3 Aspen Oss Heparin Sodium Product and Services
    • 2.8.4 Aspen Oss Heparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Aspen Oss Recent Developments/Updates
  • 2.9 Opocrin
    • 2.9.1 Opocrin Details
    • 2.9.2 Opocrin Major Business
    • 2.9.3 Opocrin Heparin Sodium Product and Services
    • 2.9.4 Opocrin Heparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Opocrin Recent Developments/Updates
  • 2.10 Qingdao Jiulong Biopharmaceutical
    • 2.10.1 Qingdao Jiulong Biopharmaceutical Details
    • 2.10.2 Qingdao Jiulong Biopharmaceutical Major Business
    • 2.10.3 Qingdao Jiulong Biopharmaceutical Heparin Sodium Product and Services
    • 2.10.4 Qingdao Jiulong Biopharmaceutical Heparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Qingdao Jiulong Biopharmaceutical Recent Developments/Updates
  • 2.11 Yino Pharma Limited
    • 2.11.1 Yino Pharma Limited Details
    • 2.11.2 Yino Pharma Limited Major Business
    • 2.11.3 Yino Pharma Limited Heparin Sodium Product and Services
    • 2.11.4 Yino Pharma Limited Heparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Yino Pharma Limited Recent Developments/Updates
  • 2.12 Dongying Tiandong Pharmaceutical
    • 2.12.1 Dongying Tiandong Pharmaceutical Details
    • 2.12.2 Dongying Tiandong Pharmaceutical Major Business
    • 2.12.3 Dongying Tiandong Pharmaceutical Heparin Sodium Product and Services
    • 2.12.4 Dongying Tiandong Pharmaceutical Heparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Dongying Tiandong Pharmaceutical Recent Developments/Updates
  • 2.13 Xinbai Pharmaceuticals
    • 2.13.1 Xinbai Pharmaceuticals Details
    • 2.13.2 Xinbai Pharmaceuticals Major Business
    • 2.13.3 Xinbai Pharmaceuticals Heparin Sodium Product and Services
    • 2.13.4 Xinbai Pharmaceuticals Heparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Xinbai Pharmaceuticals Recent Developments/Updates
  • 2.14 Laboratorios Farmaceuticos ROVI
    • 2.14.1 Laboratorios Farmaceuticos ROVI Details
    • 2.14.2 Laboratorios Farmaceuticos ROVI Major Business
    • 2.14.3 Laboratorios Farmaceuticos ROVI Heparin Sodium Product and Services
    • 2.14.4 Laboratorios Farmaceuticos ROVI Heparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Laboratorios Farmaceuticos ROVI Recent Developments/Updates
  • 2.15 Sichuan Deebio
    • 2.15.1 Sichuan Deebio Details
    • 2.15.2 Sichuan Deebio Major Business
    • 2.15.3 Sichuan Deebio Heparin Sodium Product and Services
    • 2.15.4 Sichuan Deebio Heparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Sichuan Deebio Recent Developments/Updates

3 Competitive Environment: Heparin Sodium by Manufacturer

  • 3.1 Global Heparin Sodium Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Heparin Sodium Revenue by Manufacturer (2018-2023)
  • 3.3 Global Heparin Sodium Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Heparin Sodium by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Heparin Sodium Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Heparin Sodium Manufacturer Market Share in 2022
  • 3.5 Heparin Sodium Market: Overall Company Footprint Analysis
    • 3.5.1 Heparin Sodium Market: Region Footprint
    • 3.5.2 Heparin Sodium Market: Company Product Type Footprint
    • 3.5.3 Heparin Sodium Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Heparin Sodium Market Size by Region
    • 4.1.1 Global Heparin Sodium Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Heparin Sodium Consumption Value by Region (2018-2029)
    • 4.1.3 Global Heparin Sodium Average Price by Region (2018-2029)
  • 4.2 North America Heparin Sodium Consumption Value (2018-2029)
  • 4.3 Europe Heparin Sodium Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Heparin Sodium Consumption Value (2018-2029)
  • 4.5 South America Heparin Sodium Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Heparin Sodium Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Heparin Sodium Sales Quantity by Type (2018-2029)
  • 5.2 Global Heparin Sodium Consumption Value by Type (2018-2029)
  • 5.3 Global Heparin Sodium Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Heparin Sodium Sales Quantity by Application (2018-2029)
  • 6.2 Global Heparin Sodium Consumption Value by Application (2018-2029)
  • 6.3 Global Heparin Sodium Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Heparin Sodium Sales Quantity by Type (2018-2029)
  • 7.2 North America Heparin Sodium Sales Quantity by Application (2018-2029)
  • 7.3 North America Heparin Sodium Market Size by Country
    • 7.3.1 North America Heparin Sodium Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Heparin Sodium Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Heparin Sodium Sales Quantity by Type (2018-2029)
  • 8.2 Europe Heparin Sodium Sales Quantity by Application (2018-2029)
  • 8.3 Europe Heparin Sodium Market Size by Country
    • 8.3.1 Europe Heparin Sodium Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Heparin Sodium Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Heparin Sodium Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Heparin Sodium Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Heparin Sodium Market Size by Region
    • 9.3.1 Asia-Pacific Heparin Sodium Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Heparin Sodium Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Heparin Sodium Sales Quantity by Type (2018-2029)
  • 10.2 South America Heparin Sodium Sales Quantity by Application (2018-2029)
  • 10.3 South America Heparin Sodium Market Size by Country
    • 10.3.1 South America Heparin Sodium Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Heparin Sodium Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Heparin Sodium Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Heparin Sodium Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Heparin Sodium Market Size by Country
    • 11.3.1 Middle East & Africa Heparin Sodium Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Heparin Sodium Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Heparin Sodium Market Drivers
  • 12.2 Heparin Sodium Market Restraints
  • 12.3 Heparin Sodium Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Heparin Sodium and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Heparin Sodium
  • 13.3 Heparin Sodium Production Process
  • 13.4 Heparin Sodium Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Heparin Sodium Typical Distributors
  • 14.3 Heparin Sodium Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Heparin Sodium market size was valued at USD 3472.5 million in 2022 and is forecast to a readjusted size of USD 5185.3 million by 2029 with a CAGR of 5.9% during review period.
    Heparin sodium is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots.
    Global Heparin Sodium key players include Shenzhen Hepalink, Bioibérica, Nanjing King-friend, Changshan Biochemical and Dongcheng Biochemicals. Global top five manufacturers hold a share about 57%. Europe is the largest market, with a share about 55%, followed by China and North America, total with a share about 35 percent. In terms of application, the largest application is Low Molecular Weight Heparin Preparations, followed by Standard Heparin Preparation.
    The Global Info Research report includes an overview of the development of the Heparin Sodium industry chain, the market status of Standard Heparin Preparation (Type A, Type B), Low Molecular Weight Heparin Preparations (Type A, Type B), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Heparin Sodium.
    Regionally, the report analyzes the Heparin Sodium markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Heparin Sodium market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Heparin Sodium market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Heparin Sodium industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Million Units), revenue generated, and market share of different by Type (e.g., Type A, Type B).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Heparin Sodium market.
    Regional Analysis: The report involves examining the Heparin Sodium market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Heparin Sodium market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Heparin Sodium:
    Company Analysis: Report covers individual Heparin Sodium manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Heparin Sodium This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Standard Heparin Preparation, Low Molecular Weight Heparin Preparations).
    Technology Analysis: Report covers specific technologies relevant to Heparin Sodium. It assesses the current state, advancements, and potential future developments in Heparin Sodium areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Heparin Sodium market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Heparin Sodium market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
    Market segment by Type
    Type A
    Type B
    Market segment by Application
    Standard Heparin Preparation
    Low Molecular Weight Heparin Preparations
    Major players covered
    Shenzhen Hepalink
    Nanjing King-friend
    Bioiberica
    Dongcheng Biochemicals
    Changzhou Qianhong Bio-pharma
    Pfizer
    Changshan Biochemical
    Aspen Oss
    Opocrin
    Qingdao Jiulong Biopharmaceutical
    Yino Pharma Limited
    Dongying Tiandong Pharmaceutical
    Xinbai Pharmaceuticals
    Laboratorios Farmaceuticos ROVI
    Sichuan Deebio
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Heparin Sodium product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Heparin Sodium, with price, sales, revenue and global market share of Heparin Sodium from 2018 to 2023.
    Chapter 3, the Heparin Sodium competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Heparin Sodium breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
    Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Heparin Sodium market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
    Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Heparin Sodium.
    Chapter 14 and 15, to describe Heparin Sodium sales channel, distributors, customers, research findings and conclusion.

    Buy now